NCT00428792View on ClinicalTrials.gov

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate 20 mg long-acting capsules

Trial Locations (1)

Unknown

Novartis Investigative Site, Freiburg im Breisgau

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00428792 - Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter